HOME MARKET NEWS CENTRE IPO ABOUT US Research Stock-Screener 03 May, 2024 16:48 IST Get Quote Snapshot Charts Financials Research News

my Last 5 Scrips Company BSE Price(Rs) % Chg Yes Bank 24.08 42.49 Tata Stl 136.20 30.33 Ong Corp 256.00 95.64 I T C Lt 438.65 28.62 Ntpc Ltd 319.00 89.15 Clear All Clear Last Equity NSE Live Nifty Live Prices Top Gainers/Losers Top 10 Turnover BSE Live BSE30 Live Prices Top Gainers/Losers Top 10 Turnover Market Pulse Leaders Laggards FII Activity Results Watch Results Calendar Results Announced IPO Watch Company Quotes Charts Financials Recent News Broker Research Research Research Reports	Venus Remedies Limited Pharmaceuticals - Pharmaceuticals - Others BSE:526953 NSE:VENUSREM Bloomberg:VNR@IN Reuters:VENR.BO Market Lot: 1 Face Value: 10 ISIN Demat: INE411B01019 Quotes Charts Financials Research Recent News MF Holding BSE/NSE Notices Company Announcements Venus Remedies Limited Attains GMP Certification From Libya. 18-JAN-24 Venus Remedies Limited Secures New Marketing Authorizations For DOCETAXEL And GEMCITABINE In Malta, Europe. 12-JAN-24 Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 10-JAN-24 Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 21-DEC-23 Venus Remedies Achieves Marketing Authorizations For Docetaxel In Israel And Cytarabine In Colombia. 21-DEC-23 Announcement under Regulation 30 (LODR)-Press Release / Media Release 20-DEC-23 Three New Marketing Authorizations For Enoxaparin From Bahrain. 18-DEC-23 Update Under Reg 30(LODR) 15-DEC-23 Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 07-DEC-23 Venus Remedies Granted Market Authorizations For Enoxaparin In Azerbaijan. 05-DEC-23 Announcement under Regulation 30 (LODR)-Press Release / Media Release 01-DEC-23 Unaudited Financial Results For The Quarter Ended On 30Th Sep 2023. 25-NOV-23

© All rights reserved. IRIS Business Services Limited Disclaimer